Riboswitches are regulatory elements modulating gene expression in response to specific metabolite binding. It has been recently reported that riboswitch agonists may exhibit antimicrobial properties by binding to the riboswitch domain. Guanine riboswitches are involved in the regulation of transport and biosynthesis of purine metabolites, which are critical for the nucleotides cellular pool. Upon guanine binding, these riboswitches stabilize a 5′-untranslated mRNA structure that causes transcription attenuation of the downstream open reading frame. In principle, any agonistic compound targeting a guanine riboswitch could cause gene repression even when the cell is starved for guanine. Antibiotics binding to riboswitches provide novel antimicrobial compounds that can be rationally designed from riboswitch crystal structures. Using this, we have identified a pyrimidine compound (PC1) binding guanine riboswitches that shows bactericidal activity against a subgroup of bacterial species including well-known nosocomial pathogens. This selective bacterial killing is only achieved when guaA, a gene coding for a GMP synthetase, is under the control of the riboswitch. Among the bacterial strains tested, several clinical strains exhibiting multiple drug resistance were inhibited suggesting that PC1 targets a different metabolic pathway. As a proof of principle, we have used a mouse model to show a direct correlation between the administration of PC1 and the reduction of Staphylococcus aureus infection in mammary glands. This work establishes the possibility of using existing structural knowledge to design novel guanine riboswitch-targeting antibiotics as powerful and selective antimicrobial compounds. Particularly, the finding of this new guanine riboswitch target is crucial as community-acquired bacterial infections have recently started to emerge.
Vyšlo v časopise: Novel Riboswitch Ligand Analogs as Selective Inhibitors of Guanine-Related Metabolic Pathways. PLoS Pathog 6(4): e32767. doi:10.1371/journal.ppat.1000865 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000865
1. BlountKF
BreakerRR
2006 Riboswitches as antibacterial drug targets. Nat Biotechnol 24 1558 1564
2. TalbotGH
BradleyJ
EdwardsJEJr
GilbertD
ScheldM
2006 Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42 657 668
3. PopovichKJ
HotaB
WeinsteinRA
2008 Treatment of community-associated methicillin-resistant staphylococcus aureus. Curr Infect Dis Rep 10 411 420
4. ValentiniP
ParisiG
MonacoM
CreaF
SpanuT
2008 An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann Clin Microbiol Antimicrob 7 11
5. PofelskiJ
PaveseP
BrionJP
MarrakchiC
GayE
2003 Staphylococcus aureus meningitis with intermediate sensitivity to glycopeptides. Therapeutic indications. Presse Med 32 217 220
6. LooVG
PoirierL
MillerMA
OughtonM
LibmanMD
2005 A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 2442 2449
7. KuijperEJ
CoignardB
TullP
2006 Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12 Suppl 6 2 18
8. KnowlesDJ
FoloppeN
MatassovaNB
MurchieAI
2002 The bacterial ribosome, a promising focus for structure-based drug design. Curr Opin Pharmacol 2 501 506
9. MonaghanRL
BarrettJF
2006 Antibacterial drug discovery–then, now and the genomics future. Biochem Pharmacol 71 901 909
10. SteitzTA
2005 On the structural basis of peptide-bond formation and antibiotic resistance from atomic structures of the large ribosomal subunit. FEBS Lett 579 955 958
11. BlountKF
WangJX
LimJ
SudarsanN
2007 Antibacterial lysine analogs that target lysine riboswitches. Nat Chem Biol 3 44 49
12. SudarsanN
Cohen-ChalamishS
NakamuraS
EmilssonGM
2005 Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine. Chem Biol 12 1325 1335
13. LeeER
BlountKF
2009 Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol 6
14. OttE
StolzJ
LehmannM
MackM
2009 The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biol 6 276 280
15. KimJN
LinkKH
BreakerR
2009 Design and antimicrobial action of purine analogs that bind guanine riboswitches. ACS Chem Biol 4 915 927
16. AtaideSF
WilsonSN
DangS
RogersTE
RoyB
2007 Mechanisms of resistance to an amino acid antibiotic that targets translation. ACS Chem Biol 2 819 827
17. WittorfJH
GublerCJ
1971 Coenzyme binding in yeast pyruvate decarboxylase. Kinetic studies with thiamine diphosphate analogues. Eur J Biochem 22 544 550
18. HeinrichPC
SteffenH
JanserP
WissO
1972 Studies on the reconstitution of apotransketolase with thiamine pyrophosphate and analogs of the coenzyme. Eur J Biochem 30 533 541
19. WoolleyDW
1951 An enzymatic study of the mode of action of pyrithiamine (neopyrithiamine). J Biol Chem 191 43 54
20. KozminSG
SchaaperRM
ShcherbakovaPV
KulikovVN
NoskovVN
1998 Multiple antimutagenesis mechanisms affect mutagenic activity and specificity of the base analog 6-N-hydroxylaminopurine in bacteria and yeast. Mutat Res 402 41 50
21. GilbertSD
MediatoreSJ
BateyRT
2006 Modified pyrimidines specifically bind the purine riboswitch. J Am Chem Soc 128 14214 14215
22. ShimaokaM
TakenakaY
MiharaY
KurahashiO
KawasakiH
2006 Effects of xapA and guaA disruption on inosine accumulation in Escherichia coli. Biosci Biotechnol Biochem 70 3069 3072
23. KobayashiK
EhrlichSD
AlbertiniA
AmatiG
AndersenKK
2003 Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A 100 4678 4683
24. KimJN
2008 Purine sensing by riboswitches. Biol Cell 100 1 11
25. MandalM
BoeseB
BarrickJE
WinklerWC
2003 Riboswitches control fundamental biochemical pathways in Bacillus subtilis and other bacteria. Cell 113 577 586
26. SerganovA
YuanYR
PikovskayaO
PolonskaiaA
MalininaL
2004 Structural basis for discriminative regulation of gene expression by adenine - and guanine-sensing mRNAs. Chem Biol 11 1729 1741
27. BateyRT
GilbertSD
MontangeRK
2004 Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine. Nature 432 411 415
28. MulhbacherJ
LafontaineDA
2007 Ligand recognition determinants of guanine riboswitches Nucleic Acids Res 35 5568 5580
29. PorwalS
LalS
CheemaS
KaliaVC
2009 Phylogeny in aid of the present and novel microbial lineages: diversity in Bacillus. PLoS ONE 4 e4438 doi:10.1371/journal.pone.0004438
30. MoisanH
BrouilletteE
JacobCL
Langlois-BeginP
MichaudS
2006 Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol 188 64 76
31. BischoffM
DunmanP
KormanecJ
MacapagalD
MurphyE
2004 Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J Bacteriol 186 4085 4099
32. SearsPM
McCarthyKK
2003 Management and treatment of staphylococcal mastitis. Vet Clin North Am Food Anim Pract 19 171 185
33. BrouilletteE
MalouinF
2005 The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect 7 560 568
34. MayerSJ
WatermanAE
KeenPM
CravenN
BourneFJ
1988 Oxygen concentration in milk of healthy and mastitic cows and implications of low oxygen tension for the killing of Staphylococcus aureus by bovine neutrophils. J Dairy Res 55 513 519
35. JiY
ZhangB
VanSF
Horn
WarrenP
2001 Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293 2266 2269
36. WilsonTL
JeffersJ
Rapp-GabrielsonVJ
MartinS
KleinLK
2007 A novel signature-tagged mutagenesis system for Streptococcus suis serotype 2. Vet Microbiol 122 135 145
37. McFarlandWC
StockerBA
1987 Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium. Microb Pathog 3 129 141
38. RussoTA
JodushST
BrownJJ
JohnsonJR
1996 Identification of two previously unrecognized genes (guaA and argC) important for uropathogenesis. Mol Microbiol 22 217 229
39. SamantS
LeeH
GhassemiM
ChenJ
CookJL
2008 Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 4 e37 doi:10.1371/journal.ppat.0040037
40. SwannPF
WatersTR
MoultonDC
XuYZ
ZhengQ
1996 Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273 1109 1111
41. LemayJF
PenedoJC
TremblayR
LilleyDM
2006 Folding of the adenine riboswitch. Chem Biol 13 857 868
42. BrouilletteE
GrondinG
TalbotBG
2005 Inflammatory cell infiltration as an indicator of Staphylococcus aureus infection and therapeutic efficacy in experimental mouse mastitis. Vet Immunol Immunopathol 104 163 169
43. MazzariolA
CornagliaG
NikaidoH
2000 Contributions of the AmpC beta-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to beta-lactams. Antimicrob Agents Chemother 44 1387 1390
44. SampsonBA
MisraR
BensonSA
1989 Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. Genetics 122 491 501
45. TaylorEC
LouxHM
FalcoEA
HitchingsGH
1955 Pyrimidopteridines by oxidative self-condensation of aminopyrimidines. J Am Chem Soc 77 2243 2248
46. JonesME
BoeninkNM
VerhoefJ
KohrerK
SchmitzFJ
2000 Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment. J Antimicrob Chemother 45 353 356
47. WichelhausT
SchaferV
BradeV
BoddinghausB
2001 Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus. J Antimicrob Chemother 47 153 156
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
